Cargando…

Repurposing of Miltefosine as an Adjuvant for Influenza Vaccine

We previously reported that topical imiquimod can improve the immunogenicity of the influenza vaccine. This study investigated another FDA-approved drug, miltefosine (MTF), as a vaccine adjuvant. Mice immunized with an influenza vaccine with or without MTF adjuvant were challenged by a lethal dose o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Lu, Fong, Carol Ho-Yan, Zhang, Anna Jinxia, Wu, Wai-Lan, Li, Iris Can, Lee, Andrew Chak-Yiu, Dissanayake, Thrimendra Kaushika, Chen, Linlei, Hung, Ivan Fan-Ngai, Chan, Kwok-Hung, Chu, Hin, Kok, Kin-Hang, Yuen, Kwok-Yung, To, Kelvin Kai-Wang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768360/ https://www.ncbi.nlm.nih.gov/pubmed/33322574 http://dx.doi.org/10.3390/vaccines8040754

Ejemplares similares

Improved Detection of Antibodies against SARS-CoV-2 by Microsphere-Based Antibody Assay
por: Fong, Carol Ho-Yan, et al.
Publicado: (2020)

Comparative Transcriptomic Analysis of Rhinovirus and Influenza Virus Infection
por: Dissanayake, Thrimendra Kaushika, et al.
Publicado: (2020)

Corrigendum: Comparative Transcriptomic Analysis of Rhinovirus and Influenza Virus Infection
por: Dissanayake, Thrimendra Kaushika, et al.
Publicado: (2020)

Antibody Response of BNT162b2 and CoronaVac Platforms in Recovered Individuals Previously Infected by COVID-19 against SARS-CoV-2 Wild Type and Delta Variant
por: Zhang, Ruiqi, et al.
Publicado: (2021)

Mining of linear B cell epitopes of SARS-CoV-2 ORF8 protein from COVID-19 patients
por: Wang, Xiaohui, et al.
Publicado: (2021)

Intradermal vaccination of live attenuated influenza vaccine protects mice against homologous and heterologous influenza challenges
por: Lee, Andrew Chak-Yiu, et al.
Publicado: (2021)

Assessment of population susceptibility to upcoming seasonal influenza epidemic strain using interepidemic emerging influenza virus strains
por: Chen, Lin-Lei, et al.
Publicado: (2019)

Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction
por: Lau, Siu-Ying, et al.
Publicado: (2020)

Antibody Response of Combination of BNT162b2 and CoronaVac Platforms of COVID-19 Vaccines against Omicron Variant
por: Khong, Ka-Wa, et al.
Publicado: (2022)

Absence of Vaccine-enhanced Disease With Unexpected Positive Protection Against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by Inactivated Vaccine Given Within 3 Days of Virus Challenge in Syrian Hamster Model
por: Li, Can, et al.
Publicado: (2021)

Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters
por: Zhang, Anna Jinxia, et al.
Publicado: (2020)

Pathogenesis of pandemic H1N1 2009 influenza virus infection and the implication on management
por: To, Kelvin Kai-Wang, et al.
Publicado: (2010)

Early triple antiviral therapy for COVID-19 – Authors' reply
por: Hung, Ivan Fan-Ngai, et al.
Publicado: (2020)

Correlation of Immunogenicity and Reactogenicity of BNT162b2 and CoronaVac SARS-CoV-2 Vaccines
por: Zhang, Ruiqi, et al.
Publicado: (2022)

Immunogenicity of a Heterologous Prime-Boost COVID-19 Vaccination with mRNA and Inactivated Virus Vaccines Compared with Homologous Vaccination Strategy against SARS-CoV-2 Variants
por: Zhang, Ruiqi, et al.
Publicado: (2022)

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
por: Chan, Jasper Fuk-Woo, et al.
Publicado: (2020)

Virtual screening on the web for drug repurposing: a primer
por: Chen, Yu Wai, et al.
Publicado: (2021)

Oral SARS-CoV-2 Inoculation Establishes Subclinical Respiratory Infection with Virus Shedding in Golden Syrian Hamsters
por: Lee, Andrew Chak-Yiu, et al.
Publicado: (2020)

Human metapneumovirus infection in an immunocompetent adult presenting as mononucleosis-like illness
por: Li, Iris W.S., et al.
Publicado: (2008)

Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort study
por: To, Kelvin Kai-Wang, et al.
Publicado: (2020)

Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model
por: Li, Can, et al.
Publicado: (2021)

Comparing the Relative Interfacial Affinity of Soft Colloids With Different Crosslinking Densities in Pickering Emulsions
por: Kwok, Man-hin, et al.
Publicado: (2018)

Olfactory Dysfunction in Coronavirus Disease 2019 Patients: Observational Cohort Study and Systematic Review
por: Chung, Tom Wai-Hin, et al.
Publicado: (2020)

High neutralizing antibody titer in intensive care unit patients with COVID-19
por: Liu, Li, et al.
Publicado: (2020)

No evidence for cardiotoxicity of miltefosine()
por: Dorlo, Thomas P.C.
Publicado: (2022)

Intra-host non-synonymous diversity at a neutralizing antibody epitope of SARS-CoV-2 spike protein N-terminal domain
por: Ip, Jonathan Daniel, et al.
Publicado: (2021)

SMRT sequencing revealed the diversity and characteristics of defective interfering RNAs in influenza A (H7N9) virus infection
por: Lui, Wing-Yu, et al.
Publicado: (2019)

Unexpectedly Higher Morbidity and Mortality of Hospitalized Elderly Patients Associated with Rhinovirus Compared with Influenza Virus Respiratory Tract Infection
por: Hung, Ivan F. N., et al.
Publicado: (2017)

Interferon-gamma inhibits influenza A virus cellular attachment by reducing sialic acid cluster size
por: Fong, Carol Ho-Yan, et al.
Publicado: (2022)

Neurosensory Rehabilitation and Olfactory Network Recovery in Covid-19-related Olfactory Dysfunction
por: Chung, Tom Wai-Hin, et al.
Publicado: (2021)

H7N9 influenza A virus activation of necroptosis in human monocytes links innate and adaptive immune responses
por: Lee, Andrew C. Y., et al.
Publicado: (2019)

No evidence for cardiotoxicity of miltefosine – Reply()
por: Barroso, Daniel Holanda, et al.
Publicado: (2022)

SARS-CoV-2 infects human neural progenitor cells and brain organoids
por: Zhang, Bao-Zhong, et al.
Publicado: (2020)

Age-associated SARS-CoV-2 breakthrough infection and changes in immune response in a mouse model
por: Chen, Yanxia, et al.
Publicado: (2022)

Effect of vaccine booster, vaccine type, and hybrid immunity on humoral and cellular immunity against SARS-CoV-2 ancestral strain and Omicron variant sublineages BA.2 and BA.5 among older adults with comorbidities: a cross sectional study
por: Ho-Yan Fong, Carol, et al.
Publicado: (2023)

Sporothrix spp. Biofilms Impact in the Zoonotic Transmission Route: Feline Claws Associated Biofilms, Itraconazole Tolerance, and Potential Repurposing for Miltefosine
por: dos Santos, Giulia Maria Pires, et al.
Publicado: (2022)

Clinical and Virological Factors Associated with Viremia in Pandemic Influenza A/H1N1/2009 Virus Infection
por: Tse, Herman, et al.
Publicado: (2011)

MDR1 causes resistance to the antitumour drug miltefosine
por: Rybczynska, M, et al.
Publicado: (2001)

Increased Leishmania infantum resistance to miltefosine and amphotericin B after treatment of a dog with miltefosine and allopurinol
por: Gonçalves, Gustavo, et al.
Publicado: (2021)

Characterization of an attenuated SARS-CoV-2 variant with a deletion at the S1/S2 junction of the spike protein
por: Wang, Pui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sjt97rgl5vui9f8ekqhobma3v0